Search research articles
Contact Us
Filters
Showing results (1-10 of 55) with videos related to
Page
of 6
Sort By:
The Journal of Antimicrobial Chemotherapy
|
June 26, 1999
A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'
J M Blondeau
Expert Opinion on Investigational Drugs
|
November 4, 2000
A review of clinical trials with fluoroquinolones with an emphasis on new agents
J M Blondeau
Expert Opinion on Investigational Drugs
|
February 15, 2001
Clinical utility of the new fluoroquinolones for treating respiratory and urinary tract infections
J M Blondeau
Seminars in Respiratory Infections
|
September 20, 2001
Extended-spectrum beta-lactamases
J M Blondeau
The Journal of Antimicrobial Chemotherapy
|
November 26, 2008
What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea?
J M Blondeau
Clinical Therapeutics
|
March 25, 1999
Expanded activity and utility of the new fluoroquinolones: a review
J M Blondeau
Expert Opinion on Investigational Drugs
|
November 4, 2000
Gatifloxacin: a new fluoroquinolone
J M Blondeau
Canadian Journal of Microbiology
|
November 9, 2000
A review of antimicrobial resistance in Canada
J M Blondeau, D Vaughan
Antimicrobial Agents and Chemotherapy
|
January 7, 1998
Canadian Multicenter Susceptibility Study, with a focus on cephalosporins, from 15 Canadian medical centers. The Canadian Multicenter Study Group
J M Blondeau, Y Yaschuk
International Journal of Antimicrobial Agents
|
August 5, 2000
In vitro activity of 19 antimicrobial agents against 3513 nosocomial pathogens collected from 48 Canadian medical centres. The Canadian Antimicrobial Study Group
J M Blondeau, D Vaughan
Page
of 6
Search research articles
Search
Showing results (1-10 of 55) with videos related to
Sort By:
Page
of 6
The Journal of Antimicrobial Chemotherapy
|
June 26, 1999
A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'
J M Blondeau
Expert Opinion on Investigational Drugs
|
November 4, 2000
A review of clinical trials with fluoroquinolones with an emphasis on new agents
J M Blondeau
Expert Opinion on Investigational Drugs
|
February 15, 2001
Clinical utility of the new fluoroquinolones for treating respiratory and urinary tract infections
J M Blondeau
Seminars in Respiratory Infections
|
September 20, 2001
Extended-spectrum beta-lactamases
J M Blondeau
The Journal of Antimicrobial Chemotherapy
|
November 26, 2008
What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea?
J M Blondeau
Clinical Therapeutics
|
March 25, 1999
Expanded activity and utility of the new fluoroquinolones: a review
J M Blondeau
Expert Opinion on Investigational Drugs
|
November 4, 2000
Gatifloxacin: a new fluoroquinolone
J M Blondeau
Canadian Journal of Microbiology
|
November 9, 2000
A review of antimicrobial resistance in Canada
J M Blondeau, D Vaughan
Antimicrobial Agents and Chemotherapy
|
January 7, 1998
Canadian Multicenter Susceptibility Study, with a focus on cephalosporins, from 15 Canadian medical centers. The Canadian Multicenter Study Group
J M Blondeau, Y Yaschuk
International Journal of Antimicrobial Agents
|
August 5, 2000
In vitro activity of 19 antimicrobial agents against 3513 nosocomial pathogens collected from 48 Canadian medical centres. The Canadian Antimicrobial Study Group
J M Blondeau, D Vaughan
Page
of 6